Advanced Medical Solutions Group Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/3/2026)
| Balance Sheet | Total Assets | 394,770,000.00 | ROE | 65.55 % |
| Balance Sheet | Total Equity | 258,791,000.00 | ROA | 2.52 % |
| Cashflow | Capital Expenditures | -7,358,000.00 | P/FCF | 29.06 |
| Cashflow | Free Cash Flow | 21,391,000.00 | – | – |
| Cashflow | Operating Cash Flow | 28,749,000.00 | P/CF | 21.62 |
| Income | Earnings per Share (diluted) | 0.05 | Div. Yield | 1.06 % |
| Income | Net Income | 9,954,000.00 | P/E | 56.50 |
| Income | Shares Outstanding | 220,009,000.00 | P/B | 2.40 |
| Income | Total Revenue | 228,936,000.00 | P/S | 2.71 |
Ratios calculated on: 10/14/2026
Company Description
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets worldwide. It operates in two segments, Branded and OEM. The Branded segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand; wound care products under the ActivHeal; sutures and collagen based products for the surgical and dental markets under the RESORBA; and laparoscopic device under the LiquiBand Fix8 brands. The OEM segment provides wound care platform technologies, which include alginates, foams, films, fibres, collagens, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products and bulk materials to business-to-business partners and third party convertors. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.admedsol.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more